Literature DB >> 3196154

Embryotoxic effects of thalidomide derivatives on the non-human primate Callithrix jacchus; 3. Teratogenic potency of the EM 12 enantiomers.

W Heger1, S Klug, H J Schmahl, H Nau, H J Merker, D Neubert.   

Abstract

The teratogenic potencies of the enantiomers of 2-(2,6-dioxopiperidine-3-yl)-phthalimidine ( = EM 12), a teratogenic thalidomide analogue, were investigated in Callithrix jacchus, a primate very sensitive to the teratogenic action of this thalidomide analogue. The results indicate that the S-(-)-form of EM 12 is clearly more teratogenic than the R-(+)-form. The interpretation of the studies designed to evaluate stereo-selective differences in the teratogenicity of the enantiomers becomes difficult, since both enantiomers racemise in vivo with appreciable rates (Schmahl et al. 1988a, b). Therefore, it cannot be concluded as yet that the R-(+)-form lacks all teratogenic potential.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196154     DOI: 10.1007/bf00570141

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  12 in total

1.  Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus. II. Elucidation of the susceptible period and of the variability of embryonic stages.

Authors:  D Neubert; W Heger; H J Merker; K Sames; R Meister
Journal:  Arch Toxicol       Date:  1988-01       Impact factor: 5.153

2.  [Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's transl)].

Authors:  G Blaschke; H P Kraft; K Fickentscher; F Köhler
Journal:  Arzneimittelforschung       Date:  1979

3.  The teratogenic activity of a thalidomide analogue, EM 12 in rabbits, rats, and monkeys.

Authors:  H J Schumacher; J Terapane; R L Jordan; J G Wilson
Journal:  Teratology       Date:  1972-04

4.  Non-confirmation of thalidomide induced teratogenesis in rats and mice.

Authors:  W J Scott; R Fradkin; J G Wilson
Journal:  Teratology       Date:  1977-12

5.  Determination of ovulation and pregnancy in the marmoset (Callithrix jacchus) by monitoring of urinary hydroxypregnanolone excretion.

Authors:  W Heger; D Neubert
Journal:  J Med Primatol       Date:  1987       Impact factor: 0.667

6.  Toxicity and teratogenicity of optical isomers of thalidomide.

Authors:  S Fabro; R L Smith; R T Williams
Journal:  Nature       Date:  1967-07-15       Impact factor: 49.962

7.  Comparative teratological investigation of compounds structurally and pharmacologically related to thalidomide.

Authors:  F C Helm; E Frankus; E Friderichs; I Graudums; L Flohé
Journal:  Arzneimittelforschung       Date:  1981

8.  Timing of ovulation and implantation in the common marmoset, Callithrix jacchus, by monitoring of estrogens and 6 beta-hydroxypregnanolone in urine.

Authors:  H W Heger; D Neubert
Journal:  Arch Toxicol       Date:  1983-09       Impact factor: 5.153

9.  Teratologic studies on the Himalayan rabbit: new aspects of thalidomide-induced teratogenesis.

Authors:  H Sterz; H Nothdurft; P Lexa; H Ockenfels
Journal:  Arch Toxicol       Date:  1987-07       Impact factor: 5.153

10.  The enantiomers of the teratogenic thalidomide analogue EM 12. 2. Chemical stability, stereoselectivity of metabolism and renal excretion in the marmoset monkey.

Authors:  H J Schmahl; W Heger; H Nau
Journal:  Toxicol Lett       Date:  1989-01       Impact factor: 4.372

View more
  6 in total

Review 1.  Thalidomide-type teratogenicity: structure-activity relationships for congeners.

Authors:  R L Smith; S C Mitchell
Journal:  Toxicol Res (Camb)       Date:  2018-09-26       Impact factor: 3.524

2.  Thalidomide-induced neuropathy and genetic differences in drug metabolism.

Authors:  C C Harland; G B Steventon; J R Marsden
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 3.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

4.  Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

Authors:  R Neubert; A C Nogueira; D Neubert
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

5.  Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.

Authors:  Katherine A Donovan; Jian An; Radosław P Nowak; Jingting C Yuan; Emma C Fink; Bethany C Berry; Benjamin L Ebert; Eric S Fischer
Journal:  Elife       Date:  2018-08-01       Impact factor: 8.140

6.  Overview of the marmoset as a model in nonclinical development of pharmaceutical products.

Authors:  Antonia Orsi; Daryl Rees; Isabella Andreini; Silvana Venturella; Serena Cinelli; Germano Oberto
Journal:  Regul Toxicol Pharmacol       Date:  2010-12-13       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.